Belite Bio Inc. Chief Medical Officer Hendrik Peter Scholl files Form 3 initial beneficial ownership statement

-4.64% Pre

Belite Bio, Inc. ADR

BLTE

172.76

-4.64%

0.00% Pre

Belite Bio filed an initial statement of beneficial ownership for Hendrik Peter Scholl, its chief medical officer. Scholl reported indirect beneficial ownership of 35,000 ordinary shares through Bioptima. He also reported indirect stock options for 100,000 ordinary shares with an exercise price of USD 48.68. Additional indirect stock options covered 75,000 ordinary shares at USD 54.88 and 40,000 ordinary shares at USD 158.36.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-113757), on March 18, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.